FDA’s Comprehensive Response to HIV — Part II | FDA

FDA’s Comprehensive Response to HIV — Part II | FDA

FDA's Comprehensive Response to HIV -- Global Action

The FDA is engaged on many fronts in the effort to combat HIV, applying its focus on the best available science, combined with important collaboration with many different stakeholders, industry, and patients. Yesterday I looked at some of the issues we are dealing with on the domestic front.  Today, I will examine some of the work we are doing globally, through the pivotal role we play in advancing HIV therapies in underserved global markets through the President’s Emergency Plan for AIDS Relief (PEPFAR) and through other global collaborations.

Read More